Intensive Insulin Therapy and Inflammation in Heart Surgery Patients
Author Information
Author(s): Hoedemaekers Cornelia W, Pickkers Peter, Netea Mihai G, van Deuren Marcel, Van der Hoeven Johannes G
Primary Institution: Radboud University Nijmegen Medical Centre
Hypothesis
Strict glucose regulation results in a change in cytokine balance from a pro-inflammatory state to a more balanced anti-inflammatory condition.
Conclusion
Intensive insulin therapy does not change the inflammatory response in patients after cardiac surgery.
Supporting Evidence
- Both patient groups were comparable in demographics and clinical characteristics.
- Glucose levels were significantly lower in the intensive treatment group.
- No differences were found in cytokine concentrations between the treatment groups.
- IL-6 and IL-10 levels were significantly higher in mediastinal fluid than in plasma samples.
Takeaway
This study found that giving insulin to control blood sugar levels after heart surgery doesn't change the levels of certain inflammatory substances in the body.
Methodology
Patients were randomly assigned to intensive or conventional insulin therapy, and cytokine levels were measured at various time points after surgery.
Limitations
The study only included non-diabetic patients and may not be generalizable to all cardiac surgery patients.
Participant Demographics
Non-diabetic patients undergoing elective coronary artery bypass grafting.
Statistical Information
P-Value
p<0.003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website